PLOS Biology on Nostr: How can we assess the efficacy of #tuberculosis #vaccine candidates to prioritize for ...
How can we assess the efficacy of #tuberculosis #vaccine candidates to prioritize for larger scale trials? This novel non-invasive skin challenge model uses fluorescent #BCG to enable measuring of vaccine-induced immune responses #PLOSBiology
https://plos.io/4dvTASK 
Published at
2024-08-20 09:22:07Event JSON
{
"id": "843a76432204f30b5b71e23bf5701b84c64a2396e41889cedfdeeb4d8878c340",
"pubkey": "3e45c31cdfbf1f386c345672cbc9f1be2abe7931c240e997d0f909a0d14244c8",
"created_at": 1724145727,
"kind": 1,
"tags": [
[
"t",
"tuberculosis"
],
[
"t",
"vaccine"
],
[
"t",
"BCG"
],
[
"t",
"plosbiology"
],
[
"proxy",
"https://fediscience.org/users/PLOSBiology/statuses/112993614366053991",
"activitypub"
]
],
"content": "How can we assess the efficacy of #tuberculosis #vaccine candidates to prioritize for larger scale trials? This novel non-invasive skin challenge model uses fluorescent #BCG to enable measuring of vaccine-induced immune responses #PLOSBiology https://plos.io/4dvTASK\n\nhttps://fediscience.org/system/media_attachments/files/112/993/614/257/231/316/original/8df6c05fd49b40b5.jpg",
"sig": "d71a180a295c6fcc76823426771d0e9282dd1a2bdfb62be7dd5b852dec6d804f8f6d72334fcfb40af0fd844ca22f6c4679ae455357563dd1457734df0dcd1228"
}
